Your browser doesn't support javascript.
loading
99mTC-sestamibi breast imaging: Current status, new ideas and future perspectives.
Urbano, Nicoletta; Scimeca, Manuel; Tancredi, Virginia; Bonanno, Elena; Schillaci, Orazio.
Affiliation
  • Urbano N; Nuclear Medicine, Policlinico "Tor Vergata", Viale Oxford, 81, 00133, Rome, Italy.
  • Scimeca M; Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy; University of San Raffaele, Via di Val Cannuta 247, 00166, Rome, Italy; Fondazione Umberto Veronesi (FUV), Piazza Velasca 5, 20122, Milano (Mi), Italy; UniCamillus, Saint Camillus Inter
  • Tancredi V; Department of Systems Medicine, School of Sport and Exercise Sciences, University of Rome Tor Vergata, Rome, Italy; Centre of Space Biomedicine, University of Rome Tor Vergata, Rome, Italy.
  • Bonanno E; Department of Experimental Medicine, University of Rome "Tor Vergata", Via Montpellier, 1, 00133, Rome, Italy; Diagnostica Medica' & 'Villa dei Platani', Neuromed Group, Avellino, 83100, Italy.
  • Schillaci O; Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy; IRCCS Neuromed, Pozzilli (Is), 86077, Italy. Electronic address: orazio.schillaci@uniroma2.it.
Semin Cancer Biol ; 84: 302-309, 2022 09.
Article in En | MEDLINE | ID: mdl-31982511
ABSTRACT
Here we proposed the most recent innovations in the use of Breast Specific Gamma Imaging with 99mTc-sestamibi for the management of breast cancer patients. To this end, we reported the recent discoveries concerning a) the implementation of both instrumental devices and software, b) the biological mechanisms involved in the 99mTc-sestamibi uptake in breast cancer cells, c) the evaluation of Breast Specific Gamma Imaging with 99mTc-sestamibi as predictive markers of metastatic diseases. In this last case, we also reported preliminary data about the capability of Breast Specific Gamma Imaging with 99mTc-sestamibi to identify breast cancer lesions with high propensity to form bone metastatic lesions due to the presence of Breast Osteoblast-Like Cells.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Technetium Tc 99m Sestamibi Limits: Female / Humans Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Technetium Tc 99m Sestamibi Limits: Female / Humans Language: En Year: 2022 Type: Article